Annette Langer‐Gould

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “An exploratory study of diet in childhood and young adulthood and adult-onset multiple sclerosis”.

An exploratory study of diet in childhood and young adulthood and adult-onset multiple sclerosis

Multiple Sclerosis Journal(2021)10.1177/1352458520986964

N/A

0DataRank · unranked

14 citations

Sarah Hetherton, Michaela Forkan, Edlin Gonzales, Jessica B. Smith, Alison Daly +3 more

COVID‐19 clinical outcomes and DMT of MS patients and population‐based controls

Annals of Clinical and Translational Neurology(2022)10.1002/acn3.51646

N/A

0DataRank · unranked

17 citations

Hannah Bower, Kyla A. McKay, Simon Englund, Joachim Burman, Katharina Fink +13 more

High-dose corticosteroids in patients hospitalized for COVID-19 pneumonia: an observational study of comparative effectiveness

International Journal of Infectious Diseases(2022)10.1016/j.ijid.2022.10.023

N/A

0DataRank · unranked

4 citations

Stanley Xu, Laura C. Myers, Aiyu Chen, J Greene, Beth Creekmur +5 more

Population-Based Estimates for the Prevalence of Multiple Sclerosis in the United States by Race, Ethnicity, Age, Sex, and Geographic Region

JAMA Neurology(2023)10.1001/jamaneurol.2023.1135

N/A

0DataRank · unranked

169 citations

William J. Culpepper, Annette Langer‐Gould, Ruth Ann Marrie, Gary Cutter, Wendy Kaye +6 more

De-escalating and discontinuing disease-modifying therapies in multiple sclerosis

Brain(2024)10.1093/brain/awae409

N/A

0DataRank · unranked

28 citations

Jan D. Lünemann, Élisabeth Maillart, Maria Pia Amato, Bertrand Audoin, Arlette L. Bruijstens +39 more